Bayer: urgent need for patent term extension in China
Jörg Thomaier, head of IP at Bayer, explains why PTE will help the pharma industry and what an ideal patent linkage system looks like
A patent linkage system has been on the wish list of many pharma companies in China, but Jörg Thomaier, head of IP at Bayer, sees it as a double-edged sword.
“A patent linkage system offers the opportunity for clarification for...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.